Πηγαίνετε εκτός σύνδεσης με την εφαρμογή Player FM !
Emerging MS Clinical Options
Manage episode 385239857 series 2065653
Has the place for BTK inhibitors in MS been determined? How well do extended interval or alternative B cell depletion dosing regimens work, and for which patients? Do the data support HSCT (hematopoietic stem cell transplant) over high-efficacy DMT — again, for which patients, and with what efficacy and safety?
Join us, as guest host Dr. Cole Harrington from the Ohio State University explores these important topics in this issue of eMultipleSclerosis Review.
Take our post-test to claim CME credits (https://elit.dkbmed.com/issues/178/test)
Read this podcast's companion newsletter here. (https://elit.dkbmed.com/issues/176)
Hosted on Acast. See acast.com/privacy for more information.
214 επεισόδια
Manage episode 385239857 series 2065653
Has the place for BTK inhibitors in MS been determined? How well do extended interval or alternative B cell depletion dosing regimens work, and for which patients? Do the data support HSCT (hematopoietic stem cell transplant) over high-efficacy DMT — again, for which patients, and with what efficacy and safety?
Join us, as guest host Dr. Cole Harrington from the Ohio State University explores these important topics in this issue of eMultipleSclerosis Review.
Take our post-test to claim CME credits (https://elit.dkbmed.com/issues/178/test)
Read this podcast's companion newsletter here. (https://elit.dkbmed.com/issues/176)
Hosted on Acast. See acast.com/privacy for more information.
214 επεισόδια
كل الحلقات
×Καλώς ήλθατε στο Player FM!
Το FM Player σαρώνει τον ιστό για podcasts υψηλής ποιότητας για να απολαύσετε αυτή τη στιγμή. Είναι η καλύτερη εφαρμογή podcast και λειτουργεί σε Android, iPhone και στον ιστό. Εγγραφή για συγχρονισμό συνδρομών σε όλες τις συσκευές.